Clinical trial
Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung…
NCT00005630 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005630 |
|---|---|
| Title | Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer |
| Official title | Vaccination of Non-Small Cell Lung Cancer Patients Against Mutated K-Ras: A Pilot Trial |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological |
| Interventions | ras peptide cancer vaccine, sargramostim |
| Start date | Jul 1, 1999 |
| Primary completion | May 1, 2002 |
| Completion | May 1, 2002 |
| First posted | Oct 1, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: